Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 02/09/23 | EFFECT | Notice of Effectiveness |
|
1 | |
| 02/09/23 | EFFECT | Notice of Effectiveness |
|
1 | |
| 02/09/23 | EFFECT | Notice of Effectiveness |
|
1 | |
| 02/09/23 | EFFECT | Notice of Effectiveness |
|
1 | |
| 02/09/23 | EFFECT | Notice of Effectiveness |
|
1 | |
| 02/09/23 | EFFECT | Notice of Effectiveness |
|
1 | |
| 02/09/23 | EFFECT | Notice of Effectiveness |
|
1 | |
| 02/09/23 | EFFECT | Notice of Effectiveness |
|
1 | |
| 02/03/23 | POS AM | Post-effective amendment to a registration statement that is not immediately effective upon filing |
|
4 | |
| 02/03/23 | POS AM | Post-effective amendment to a registration statement that is not immediately effective upon filing |
|
4 |
